Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
APRE holding history
Aprea Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APRE overviewAll 13F holders of APREFull Q2 2026 holdings
- Shares (Q2 2026)
- 58,600
- Value
- $47.0K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 58,600 | $47.0K | <0.1% | +58,600 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −51,041−100.0% | Sold out | Holders |
| Q4 2025 | 51,041 | $43.5K | <0.1% | +51,041 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −30,083−100.0% | Sold out | Holders |
| Q1 2025 | 30,083 | $61.4K | <0.1% | +30,083 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −64−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q4 2022 | 1,276 | $411 | <0.1% | +1,276 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −18,881−100.0% | Sold out | Holders |
| Q2 2022 | 18,881 | $14.0K | <0.1% | −58,201−75.5% | Reduced | Holders |
| Q1 2022 | 77,082 | $143.0K | <0.1% | −86,179−52.8% | Reduced | Holders |
| Q4 2021 | 163,261 | $469.0K | <0.1% | +41,312+33.9% | Added | Holders |
| Q3 2021 | 121,949 | $623.0K | <0.1% | +93,330+326.1% | Added | Holders |
| Q2 2021 | 28,619 | $140.0K | <0.1% | +28,619 | New | Holders |